Evidence map›Paper›PMID 32685159›Full record

ReviewArrhythmia & electrophysiology review2020

Non-invasive Stereotactic Radioablation: A New Option for the Treatment of Ventricular Arrhythmias.

Chen Wei, Pierre Qian, Usha Tedrow, Raymond Mak, Paul C Zei

Abstract readReview
In one paragraph

Review in Arrhythmia & electrophysiology review, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Cardiac radioablation in the treatment of ventricular tachycardia.Clinical and translational radiation oncology · 2021
    Review
  9. Review
  10. Review
  11. Progression of infarct-mediated arrhythmogenesis in a rodent model of heart failure.American journal of physiology. Heart and circulatory physiology · 2021
    Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Chen WeiHarvard Medical School, Boston, MA, US.
Pierre QianDivision of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA, US.
Usha TedrowDivision of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA, US.
Raymond MakDepartment of Radiation Oncology, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Boston, MA, US.
Paul C ZeiDivision of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA, US.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ventricular tachycardia (VT) is associated with significant morbidity and mortality. Radiofrequency catheter ablation can be effective for the treatment of VT but it carries a high rate of recurrence often attributable to insufficient depth of penetration for reaching critical arrhythmogenic substrates. Stereotactic body radioablation (SBRT) is a commonly used technology developed for the non-invasive treatment of solid tumours. Recent evidence suggests that it can also be effective for the treatment of VT. It is a non-invasive procedure and it has the unique advantage of delivering ablative energy to any desired volume within the body to reach sites that are inaccessible with catheter ablation. This article summarises the pre-clinical studies that have formed the evidence base for SBRT in the heart, describes the clinical approaches for SBRT VT ablation and provides perspective on next steps for this new treatment modality.

Indexed as

Ablationcardiac arrhythmiasnoninvasiveradiosurgeryradiotherapystereotacticventricular tachycardia

Identifiers

PMID32685159
PMCPMC7358955

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.